Zhang, 2002 - Google Patents
Syntheses of insulins: From in vivo to in vitro to in vivoZhang, 2002
View PDF- Document ID
- 4063522491639558544
- Author
- Zhang Y
- Publication year
- Publication venue
- Peptides Biology and Chemistry: Proceedings of the 1996 Chinese Peptide Symposium July 21–25, 1996, Chengdu, China
External Links
Snippet
Insulin was first isolated from the canine pancreas by Banting and Best in 1921. On the occasion of the 75th anniversary of this great discovery in biology and medicine, it is appropriate to review briefly studies on insulin syntheses in which my colleagues and I have …
- 108090001061 Insulin 0 title abstract description 60
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormones [GH] (Somatotropin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8633156B2 (en) | Insulin derivatives having an extremely delayed time-action profile | |
RU2529952C2 (en) | Novel insulin derivatives with strongly slowed profile time/action | |
US7790677B2 (en) | Insulin production methods and pro-insulin constructs | |
JP4291900B2 (en) | An improved method for obtaining insulin precursors with correctly bound cystine bridges | |
US9644017B2 (en) | Insulin derivatives having an extremely delayed time-action profile | |
KR0173478B1 (en) | Parathyroid hormone antagonists | |
JP2011526886A (en) | Novel insulin analogues with sustained activity | |
IE921862A1 (en) | A-c-b proinsulin, method of manufacturing and using same,¹and intermediates in insulin production | |
KR20020073184A (en) | Process for Solubilizing Glucagon-Like Peptide 1 Compounds | |
ES2279510T5 (en) | HUMAN INSULIN GENERATION. | |
CA2083360A1 (en) | Tri-arginine insulins | |
CN113105536B (en) | New proinsulin glargine and method for preparing insulin glargine by using same | |
JPH08301899A (en) | Igf-1 superagonist | |
JP2009542235A (en) | Method for producing an insulin analogue having a dibasic B chain end | |
AU2003236080B8 (en) | A method for producing a modified peptide | |
KR100989413B1 (en) | Process for producing recombinant protein using novel fusion partner | |
CN113614113B (en) | Fusion proteins containing fluorescent protein fragments and uses thereof | |
US7659363B2 (en) | Process for the preparation of insulin or an insulin derivative in the presence of oxygen | |
Zhang | Syntheses of insulins: From in vivo to in vitro to in vivo | |
US20160024168A1 (en) | Aspart proinsulin compositions and methods of producing aspart insulin analogs | |
RU2004137000A (en) | MUTEINS OF PLACENTAL GROWTH FACTOR, TYPE 1, METHOD FOR PRODUCING THEM AND APPLICATION | |
CN116789801A (en) | Novel insulin derivatives and uses thereof | |
WO2019143193A1 (en) | N-terminal fusion partner for producing recombinant polypeptide, and method for producing recombinant polypeptide using same | |
CS271191A3 (en) | Enzymatic process of pre-proinsulins to insulins conversion | |
ZA200404273B (en) | Insulin molecule having protracted time action. |